← Feed

Daniell Richard

SEC Form 4 insider
EVP, Europe Commercial · TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA)
1 thesis · first seen Nov 12, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$TEVASEC Form 4bearish
Daniell Richard · EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD · 20h agono track record yet
Sold 45,003 @ $42.86 avg · $1,928,944 · 2026-11-09

Form 4: Daniell Richard sold TEVA

Daniell Richard (EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD) reported an open-market sale of 45,003 shares of TEVA at an average $42.86, roughly $1,928,944, in a Form 4 filed 2026-11-12.

Now $43.65as of Nov 12, 4:31 PM ET
View filing on SEC.gov →

End of results.